Company intelligence / Profile preview
Cymra Life Sciences
- Ownership
- Private
- Development stage
- Commercial
Overview
Cymra Life Sciences is running observational trials on chronic pain in collaboration with Applied Cannabis Research and CA Clinics. They develop full spectrum cannabis medicines targeting pharmaceutical and nutraceutical markets worldwide.
- Therapeutic areas
- ImmunologyPsychiatryNeurology
- Modalities
- Full spectrum cannabis medicinesPlant-based medicines
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Cymra Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cymra Life Sciences.